Quantcast
Last updated on April 23, 2014 at 11:18 EDT

Latest Multi-drug-resistant tuberculosis Stories

2011-10-27 01:00:00

LILLE, France, Oct. 27, 2011 /PRNewswire/ -- The Eli Lilly and Company Foundation has committed US $30 million in funding to further support The Lilly MDR-TB Partnership in its fight against multidrug-resistant tuberculosis - a disease that disproportionately affects developing countries and kills more than 150,000 people each year. The announcement was made ahead of the opening of the 42nd Union World Conference on Lung Health in Lille, France, later this week. Eli Lilly and Company...

2011-10-20 13:44:04

Cambodian study demonstrates that starting antiretroviral treatment two weeks, not two months, after TB treatment increases survival 33 percent Timing is everything when treating patients with both HIV and tuberculosis. Starting HIV therapy in such patients within two weeks of TB treatment, rather than two months as is the current practice, increases survival by 33 percent, according to a large-scale clinical trial in Cambodia led by researchers at Children's Hospital Boston and the Immune...

2011-10-19 16:00:00

Cambodian study demonstrates that starting antiretroviral treatment two weeks, not two months, after TB treatment increases survival 33 percent BOSTON, Oct. 19, 2011 /PRNewswire-USNewswire/ -- Timing is everything when treating patients with both HIV and tuberculosis. Starting HIV therapy in such patients within two weeks of TB treatment, rather than two months as is the current practice, increases survival by 33 percent, according to a large-scale clinical trial in Cambodia led by...

2011-09-27 07:00:00

INDIANAPOLIS, Sept. 26, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of a new open innovation platform designed to help build the company's pipeline of tomorrow and, from a philanthropic perspective, identify molecules that may have application for treating multi-drug resistant tuberculosis (MDR-TB). The new platform, titled Open Innovation Drug Discovery, is supported by an innovative new website available at openinnovation.Lilly.com. It builds on the...

2011-08-04 13:17:52

The European Respiratory Journal is today (04 August 2011) publishing the updated guidelines of the World Health Organization (WHO) that aim to help manage drug-resistant tuberculosis (TB). The new document 'The WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update' focuses on priority areas for healthcare professionals in the diagnosis, treatment and care of drug-resistant TB. It also calls for more research to guide the management of the condition. TB is...

2011-07-27 05:59:27

(Ivanhoe Newswire) -- Two research studies suggest that a new automated DNA test for tuberculosis (Xpert MTB/RIF), which can detect TB within 2 hours and has been endorsed by the World Health Organization, can significantly increase TB detection rate compared to other tests, particularly in HIV positive patients who have a high risk of being infected with TB, including multidrug resistant TB. In the first study, led by Stephen Lawn from the Desmond Tutu HIV Centre at the University of Cape...

2011-05-18 06:51:43

(Ivanhoe Newswire) "“ Patients with tuberculosis (TB) who wear a simple facemask may be able to greatly cut transmission rates to non-infected patients, according to a study conducted on guinea pigs. "We found that when infectious patients with multidrug resistant tuberculosis (MDR-TB) wore face masks while they were hospitalized, the face masks helped decrease the transmission of tuberculosis by 50 percent compared to when the patients did not wear face masks," study author Ashwin...

2011-05-05 13:11:10

Big and messy, but a necessary partner in stopping the TB epidemic Tuberculosis (TB) is widely considered a public health concern and its treatment a public sector responsibility. But according to a study published today in the journal PLoS ONE, the private sector for TB treatment is ignored at our peril. Across 10 high-burden countries, there is as much TB drug volume in the private sector as in the public sector"”and at least a third of all private sector dosages of first-line TB...

2011-03-25 00:00:30

MSF report says fixing drug supply and price problems is urgent Geneva / Johannesburg (Vocus/PRWEB) March 24, 2011 A promising new diagnostic test will finally help detect more people with drug-resistant tuberculosis (DR-TB), a development that lends greater urgency to solve major problems surrounding the pricing and supply of DR-TB medicines, according to a report released today by the international medical humanitarian organization Doctors Without Borders/Médecins Sans...

2011-03-16 14:17:16

The standard approach to re-treating tuberculosis (TB) in low and middle income settings is failing, according to research funded by the Wellcome Trust. In a study published today in the open access journal PLoS Medicine, researchers call for improved access to rapid diagnostics for drug resistant TB, second-line TB treatment and antiretroviral HIV therapy. Each year, between one in ten and one in five patients treated for TB see their disease return after failing, interrupting or relapsing...